BAA research area 001: development of vaccine candidates for biodefense, antimicrobial resistant (AMR) infections and emerging infectious diseases
Active Definitive Contract Awarded Last action
- Contract number
- 75N93023C00019
- Awardee
-
Icahn School Of Medicine At Mount Sinai UEI C8H9CNG1VBD9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,898,493
Award facts
- Opportunity
-
- BAA20221 Solicitation number
- Contract value 70% obligated
-
- $15,898,493.00 Current, with exercised options
- $22,709,915.00 Potential, with all options
- Completion date 69% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 19 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- New York, NY 10029, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $15,898,493 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $22.7 million definitive contract to Icahn School of Medicine at Mount Sinai for development of vaccine candidates for biodefense, antimicrobial-resistant infections, and emerging infectious diseases on June 1, 2023, under cost-no-fee pricing with ultimate completion May 31, 2028.
Place of performance is New York, NY. The originating solicitation targets BAA Research Area 001, covering vaccine candidate development across the three priority infectious disease domains. The contract is a full-and-open procurement without set-aside.
Icahn School of Medicine at Mount Sinai is a tax-exempt academic medical center and established NIH research performer with substantial existing portfolio depth in biomedical research and clinical services. The institution competes predominantly as a prime recipient across federally funded research, with the National Institute of Allergy and Infectious Diseases representing the largest customer concentration (379 awards, $555.6 million combined potential value across the broader institution).
Subcontractors named on this award include Bioreliance Corporation (quality control release testing for Newcastle Disease Virus–derived vaccine products including sterility, endotoxin, and bioburden assays), Meridian Life Science Inc. (egg infectious dose testing and stability assessments for NDV cGMP biological samples), and University of Maryland, Baltimore (Phase 1 clinical trial design, immunologic and virologic assays, and regulatory preparation for a SARS-CoV-2 multivalent vaccine).
Service Contract Inventory data shows actual government-invoiced labor of $3.7 million across FY2025 at 13.0 FTEs and 27,069 contractor hours, with a derived government-paid hourly rate of $136.01/hr (rising from $66.33/hr in FY2023). Subcontractor engagement is minimal at 1% of hours.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Bioreliance Corporation | $726,922 | |
| Meridian Life Science Inc. | $152,968 | |
| University Of Maryland, Baltimore | $463,227 |
Quick answers
Who was awarded contract 75N93023C00019?
75N93023C00019 was awarded to Icahn School Of Medicine At Mount Sinai by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 1, 2023.
How much is contract 75N93023C00019 worth?
The government has obligated $15,898,493 on 75N93023C00019. Its potential value, with all options, is $22,709,915.
Was contract 75N93023C00019 competed?
The extent of competition for 75N93023C00019 was full and open competition. The government received 19 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award